Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Riluzole (RP-54274) is a glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
50 mg | 在庫あり | ¥ 10,500 | |||
100 mg | 在庫あり | ¥ 13,500 | |||
500 mg | お問い合わせ | ¥ 27,000 | |||
1 g | お問い合わせ | ¥ 36,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 11,500 |
説明 | Riluzole (RP-54274) is a glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS. |
ターゲット&IC50 | GABA:43 μM |
別名 | PK 26124, RP-54274 |
分子量 | 234.2 |
分子式 | C8H5F3N2OS |
CAS No. | 1744-22-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 43 mg/mL (183.6 mM)
H2O: < 1 mg/mL (insoluble or slightly soluble)
Ethanol: 43 mg/mL (183.6 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Riluzole 1744-22-5 Membrane transporter/Ion channel Neuroscience NMDAR Sodium Channel GABA Receptor Gamma-aminobutyric acid Receptor PK 26124 RP 54274 PK26124 PK-26124 RP54274 γ-Aminobutyric acid Receptor RP-54274 inhibit Na+ channels Inhibitor Na channels inhibitor